251 related articles for article (PubMed ID: 30617460)
1. An Overview on Arsenic Trioxide-Induced Cardiotoxicity.
Vineetha VP; Raghu KG
Cardiovasc Toxicol; 2019 Apr; 19(2):105-119. PubMed ID: 30617460
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 Fatty Acid Protects Against Arsenic Trioxide-Induced Cardiotoxicity In Vitro and In Vivo.
Varghese MV; Abhilash M; Paul MV; Alex M; Nair RH
Cardiovasc Toxicol; 2017 Apr; 17(2):109-119. PubMed ID: 26886836
[TBL] [Abstract][Full Text] [Related]
3. L-ascorbic acid and α-tocopherol attenuate arsenic trioxide-induced toxicity in H9c2 cardiomyocytes by the activation of Nrf2 and Bcl2 transcription factors.
Vineetha RC; Binu P; Arathi P; Nair RH
Toxicol Mech Methods; 2018 Jun; 28(5):353-360. PubMed ID: 29297235
[TBL] [Abstract][Full Text] [Related]
4. Honokiol attenuate the arsenic trioxide-induced cardiotoxicity by reducing the myocardial apoptosis.
Huang AL; Yang F; Cheng P; Liao DY; Zhou L; Ji XL; Peng DD; Zhang L; Cheng TT; Ma L; Xia XG
Pharmacol Res Perspect; 2022 Apr; 10(2):e00914. PubMed ID: 35171536
[TBL] [Abstract][Full Text] [Related]
5. Effects of anticancer drugs on the cardiac mitochondrial toxicity and their underlying mechanisms for novel cardiac protective strategies.
Kim CW; Choi KC
Life Sci; 2021 Jul; 277():119607. PubMed ID: 33992675
[TBL] [Abstract][Full Text] [Related]
6. Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats.
Zhao Z; Li J; Zheng B; Liang Y; Shi J; Zhang J; Han X; Chu L; Chu X; Gao Y
Mol Med Rep; 2020 Dec; 22(6):5271-5281. PubMed ID: 33173984
[TBL] [Abstract][Full Text] [Related]
7. Phloretin ameliorates arsenic trioxide induced mitochondrial dysfunction in H9c2 cardiomyoblasts mediated via alterations in membrane permeability and ETC complexes.
Vineetha VP; Soumya RS; Raghu KG
Eur J Pharmacol; 2015 May; 754():162-72. PubMed ID: 25746422
[TBL] [Abstract][Full Text] [Related]
8. The Cardiotoxicity Induced by Arsenic Trioxide is Alleviated by Salvianolic Acid A via Maintaining Calcium Homeostasis and Inhibiting Endoplasmic Reticulum Stress.
Wang R; Zhang J; Wang S; Wang M; Ye T; Du Y; Xie X; Ye J; Sun G; Sun X
Molecules; 2019 Feb; 24(3):. PubMed ID: 30717322
[TBL] [Abstract][Full Text] [Related]
9. Activation of the ubiquitin-proteasome system against arsenic trioxide cardiotoxicity involves ubiquitin ligase Parkin for mitochondrial homeostasis.
Watanabe M; Funakoshi T; Unuma K; Aki T; Uemura K
Toxicology; 2014 Aug; 322():43-50. PubMed ID: 24801902
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide toxicity in H9c2 myoblasts--damage to cell organelles and possible amelioration with Boerhavia diffusa.
Vineetha VP; Prathapan A; Soumya RS; Raghu KG
Cardiovasc Toxicol; 2013 Jun; 13(2):123-37. PubMed ID: 23161055
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying the protective effect of tannic acid against arsenic trioxide‑induced cardiotoxicity in rats: Potential involvement of mitochondrial apoptosis.
Xue Y; Li M; Xue Y; Jin W; Han X; Zhang J; Chu X; Li Z; Chu L
Mol Med Rep; 2020 Dec; 22(6):4663-4674. PubMed ID: 33173965
[TBL] [Abstract][Full Text] [Related]
12. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline Attenuates Arsenic Trioxide-Induced Cardiac Oxidative Damage in Mice.
Gholami A; Ataei S; Ahmadimoghaddam D; Omidifar N; Nili-Ahmadabadi A
Oxid Med Cell Longev; 2021; 2021():6406318. PubMed ID: 33505582
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide-induced cardiotoxicity triggers ferroptosis in cardiomyoblast cells.
Wang L; Liu S; Gao C; Chen H; Li J; Lu J; Yuan Y; Zheng X; He H; Zhang X; Zhang R; Zhang Y; Wu Y; Lin W; Zheng H
Hum Exp Toxicol; 2022; 41():9603271211064537. PubMed ID: 35195477
[TBL] [Abstract][Full Text] [Related]
15. Effect and mechanism of Sorbus pohuashanensis (Hante) Hedl. flavonoids protect against arsenic trioxide-induced cardiotoxicity.
Yu X; Wang Z; Shu Z; Li Z; Ning Y; Yun K; Bai H; Liu R; Liu W
Biomed Pharmacother; 2017 Apr; 88():1-10. PubMed ID: 28092839
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia.
Gao C; Hu S; Guo M; Hai X; Zhou J
Cancer Chemother Pharmacol; 2018 Aug; 82(2):229-236. PubMed ID: 29845392
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo.
Zhao XY; Li GY; Liu Y; Chai LM; Chen JX; Zhang Y; Du ZM; Lu YJ; Yang BF
Br J Pharmacol; 2008 May; 154(1):105-13. PubMed ID: 18332854
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Imaging in Cardio-oncology.
Tong D; Zaha VG
J Cardiovasc Transl Res; 2020 Jun; 13(3):357-366. PubMed ID: 31696405
[TBL] [Abstract][Full Text] [Related]
19. Can ErbB2 overexpression protect against doxorubicin cardiotoxicity?
Rocic P
Am J Physiol Heart Circ Physiol; 2015 Oct; 309(8):H1235-6. PubMed ID: 26297228
[No Abstract] [Full Text] [Related]
20. Aloin protects against arsenic trioxide-induced myocardial membrane damage and release of inflammatory cytokines.
Birari LA; Mahajan UB; Patil KR; Patil DD; Bagul NA; Belemkar S; Goyal SN; Ojha S; Patil CR
Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug; 393(8):1365-1372. PubMed ID: 32025748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
